60
Views
5
CrossRef citations to date
0
Altmetric
Guidelines on Antimicrobial Chemotherapy for Prevention and Treatment of Infections in the Intensive Care Unit

Mechanisms of Tissue Injury in Sepsis: Contrasts between Gram Positive and Gram Negative Infection

References

  • Cohen J, Abraham E. Microbiologic findings and corre-lations with serum Tumor Necrosis Factor-a in patients with severe sepsis and septic shock. J Infect Dis 1999; 180: 116–121.
  • Rangel-Frausto M. The epidemiology of bacterial sepsis. Infect Dis Clin North Am 1999; 13 (2): 299–312.
  • Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999; 27 (5): 887–892.
  • Opal SM, Cohen J. Are there fundamental differences of clinical relevance between Gram positive and Gram nega-tive bacterial sepsis? Crit Care Med 1999; 27: 1608-1616.
  • Sriskandan S, Cohen J. Gram positive sepsis: mecha-nisms and differences from Gram negative sepsis. Infect Dis Clin North Am 1999; 13 (2): 397–412.
  • Morrison DC, Danner RL, Dinarello CA, et al. Bacterial endotoxins and pathogenesis of Gram-negative infections: cur-rent status and future direction. J Endotoxin Res 1994; 1: 71–83.
  • Hurley JC. Endotoxemia: methods of detection and clin-ical correlates. Clin Microbiol Rev 1995; 8: 268–292.
  • Cohen J. The detection and interpretation of endotox-aemia. Intensive Care Med 2000; 26 (Suppl 1): S51–S56.
  • Maury E, Barakett V, Blanchard H, et al. Circulating endotoxin during initial antibiotic treatment of severe Gram-negative bacteremic infections. J Infect Dis 1998; 178: 270–273.
  • Opal SM, Scannon PJ, Vincent J-L, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999; 180: 1584–1589.
  • Hurley JC. Concordance of endotoxemia with Gram negative bacteremia. A meta-analysis using receiver operating characteristic curves. Arch Pathol Lab Med 2000; 124: 1157–1164.
  • Heumann D, Barras C, Severin A, Glauser M-P, Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 1994; 62: 2715-2721.
  • De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Nati Acad Sci USA 1995; 92: 10359–10363.
  • Majcherczyk PA, Langen H, Heumann D, Fountoulakis M, Glauser M-P, Moreillon P. Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity. J Biol Chem 1999; 274 (18): 12537–12543.
  • van Langevelde P, van Dissel JT, Ravensbergen E, Appelmelk BJ, Schrijver IA, Groeneveld PH. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and bio-logical reactivities. Antimicrob Agents Chemother 1998; 42 (12): 3073–3078.
  • Kengatharan M, De Kimpe SJ, Robson C, Foster S, Thiemermann C. Mechanism of Gram positive shock: identifi-cation of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med 1998; 188: 305–315.
  • Gao JJ, Xue Q, Zuvanich EG, Haghi KR, Morrison DC. Commercial preparations of lipoteichoic acid contain endotox-in that contributes to activation of mouse macrophages in vitro. Infect Immun 2001; 69 (2): 751–757.
  • Lavoie PM, Thibodeau J, Erard F, Sekaly RP. Understanding the mechanism of action of bacterial superanti-gens from a decade of research. Immunol Rev 1999; 168: 257–269.
  • Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321: 1–7.
  • Stevens DL. Streptococcal toxic shock syndrome asso-ciated with necrotizing fasciitis. Ann Rev Med 2000; 51: 271–288.
  • Sriskandan S, Moyes D, Cohen J. Detection of circulat-ing bacterial superantigen and lymphotoxin-a in patients with streptococcal toxic-shock syndrome. Lancet 1996; 348: 1315–1316.
  • Schlievert PM. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect Immun 1982; 36: 123–128.
  • Heumann D, Glauser M-P. Pathogenesis of sepsis. Scientific American Sci Med 1994; 1 (5): 28–37.
  • Noursedeghi M, Cohen J. Immunopathogenesis of severe sepsis. J Roy Coll Phys Lond 2000; 34: 432–436.
  • Wurfel MM, Hailman E, Wright SD. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 1995; 181: 1743-1754.
  • Yu B, Hailman E, Wright SD. Lipopolysaccharide bind-ing protein and soluble CD14 catalyze exchange of phospho-lipids. J Clin Invest 1997; 99 (2): 315–324.
  • Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996; 64: 1906-1912.
  • Cauwels A, Wan E, Leismann M, Tuomanen E. Coexistence of CD14-dependent and independent pathways for stimulation of human monocytes by gram-positive bacteria. Infect Immun 1997; 65: 3255-3260.
  • Jin Y, Gupta D, Dziarski R. Endothelial and epithelial cells do not respond to complexes of peptidoglycan with solu-ble CD14 but are activated indirectly by peptidoglycan-induced tumor necrosis factor-a and interleukin-1 from monocytes. J Infect Dis 1998; 177: 1629-1638.
  • Aderem A, Ulevitch RJ. Toll-like receptors in the induc-tion of the innate immune response. Nature 2000; 406: 782–787.
  • Poltorak A, He X, Smirnova I, et al. Defective LPS sig-naling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science 1998; 282 (5396): 2085–2088.
  • Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11: 443–451.
  • Dziarski R, Ulmer AJ, Gupta D. Interactions of CD14 with components of gram-positive bacteria. Chem Immunol 2000; 74: 83–107.
  • Andersson J, Nagy S, Björk L, Abrams J, Holm S, Andersson U. Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol Rev 1992; 127: 69–96.
  • Cohen J, Lynn WA. Septic shock: From experimental models to the bedside. Rev Clin Exp Hematol 1998; 7: 23–56.
  • Wiles JB, Cerra FB, Siegel JH, Border JR. The sys-temic septic response: does the organism matter? Crit Care Med 1980; 8 (2): 55–60.
  • Ahmed J, Kruse JA, Haupt MT, Chandrasekar PH, Carlson RW. Hemodynamic responses to Gram-positive versus Gram-negative sepsis in critically ill patients with and without circulatory shock. Crit Care Med 1991; 19: 1520–1525.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.